首页> 外文OA文献 >BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity

【2h】

BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity

机译：BoDi-Pt，一种绿色可激活和基于卡铂的铂（IV）抗癌前药，增强的活化和细胞毒性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 -1
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity [J] . Yao Houzong, Chen Shu, Deng Zhiqin, Inorganic Chemistry: A Research Journal that Includes Bioinorganic, Catalytic, Organometallic, Solid-State, and Synthetic Chemistry and Reaction Dynamics . 2020,第16期

机译：BoDi-Pt，一种绿色可激活和基于卡铂的铂（IV）抗癌前药，增强的活化和细胞毒性
2. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues [J] . Chen Shu, Yao Houzong, Zhou Qiyuan, Inorganic Chemistry: A Research Journal that Includes Bioinorganic, Catalytic, Organometallic, Solid-State, and Synthetic Chemistry and Reaction Dynamics . 2020,第16期

机译：铂（IV）抗癌前药的稳定性，减少和细胞毒性携带氨基甲酸酯轴向配体：与其羧酸盐类似物的比较
3. Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells [J] . Yao Houzong, Xu Zoufeng, Li Cai, Inorganic Chemistry: A Research Journal that Includes Bioinorganic, Catalytic, Organometallic, Solid-State, and Synthetic Chemistry and Reaction Dynamics . 2019,第16期

机译：铂（IV）抗癌前药的合成与细胞毒性研究，选择性促进丁氏素释放激素（LHRH）受体阳性癌细胞
4. Drugs to Enhance the Therapeutic Potency of Anticancer Antibodies: Antibody-Drug Conjugates as Tumor-Activated Prodrugs [C] . Walter A. Blattler, Ravi V. J. Chari American Chemical Society . 2001

机译：药物以增强抗癌抗体治疗效力：抗体 - 药物缀合物作为肿瘤活化前药
5. Targeting and selectivity of anticancer prodrug: Activation by peptidase-DPP IV. [D] . Yang, Pei-Hua. 2007

机译：抗癌前药的靶向和选择性：肽酶-DPP IV的激活。
6. Cetuximab-decorated and NIR-activated Nanoparticles Based on Platinum(IV)-prodrug: Preparation Characterization and In-vitro Anticancer Activity in Epidermoid Carcinoma Cells [O] . Yu Wang, Xin-Ming Zhang, Yu Sun, 2021

机译：基于铂（IV）的铂（IV）-Prodrug：表征癌细胞中的制备表征和体外抗癌活性的甲磺酸纤维瘤和活化的纳米颗粒
7. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues [O] . -1

机译：铂（IV）抗癌前药的稳定性，减少和细胞毒性携带氨基甲酸酯轴向配体：与其羧酸盐类似物的比较

BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity

著录项

引文网络

相似文献

相关主题

期刊订阅